Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00845624 · ClinicalTrials.gov registry record
Time Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm Infants
A clinical trial of Retinopathy of Prematurity, sponsored by University of Virginia.
- Completed
- Registry status
- 102
- Enrollment target
- 1
- Study location
NCT00845624 is a study of Retinopathy of Prematurity that has completed, run by University of Virginia. The registered enrollment target is 102 participants, below the 354-participant average among 7 other Retinopathy of Prematurity trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00845624, a study of Retinopathy of Prematurity, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if there is a relationship between time spent out the targeted oxygen saturation range in preterm infants is associated with long-term outcomes such as Retinopathy of Prematurity.
Conditions Studied
Study Locations (1)
Virginia
- University of Virginia Neonatal Intensive Care Unit - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00845624
The ClinicalTrials.gov registry entry for NCT00845624 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 354-participant average among 7 other Retinopathy of Prematurity trials with a reported enrollment target (71% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinopathy of Prematurity appearing as the primary indexed condition, and to 0 interventions.
NCT00845624 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00845624 about?
NCT00845624 is a clinical study titled "Time Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm Infants". The purpose of this study is to determine if there is a relationship between time spent out the targeted oxygen saturation range in preterm infants is associated with long-term outcomes such as Retinopathy of Prematurity.
What is the current status of trial NCT00845624?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2007-01. Estimated completion is 2009-06.
What conditions does trial NCT00845624 study?
This clinical trial studies the following conditions: Retinopathy of Prematurity.
Who is sponsoring clinical trial NCT00845624?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00845624 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinopathy of Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Retinal Vasculature in Infant Eyes
RECRUITING
-
Clinical and Genetic Analysis of ROP
RECRUITING
-
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
RECRUITING · NA
-
Bevacizumab Treatment For Type 1 ROP
ACTIVE NOT RECRUITING · Phase 2
-
Validation of i-ROP DL to Detect More Than Mild ROP
ACTIVE NOT RECRUITING · NA
-
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.